Unlock and Upgrade

Remove all limits from your Quizzes

You've reached the limit of our free version but can immediately unlock and go pro.

Test your knowledge on managing a patient newly diagnosed with MM and ineligible for stem-cell transplant

The induction regimen of daratumumab, lenalidomide, and dexamethasone is appropriate for induction therapy for a newly diagnosed transplant-ineligible patient given its ability to achieve which of the following?

Produce high levels of minimal residual disease

Prolong overall survival

Have a PFS of 34.4 months

Reduce the risk of hypersensitivity reactions

Bone disease in multiple myeloma is a result of which of the following?

Induced osteoblast function

Plasma cells reducing osteoclast function

Osteoclastic bone destruction

Bone-modifying agents

The results of the EMNO11/HOVON114 trial demonstrated which of the following, regarding KPd?

It is an effective regimen in front-line therapy for transplant-ineligible patients

It is an effective regimen for patients who are refractory to pomalidomide

It is an effective regimen with no VTE risk

It is an effective regimen for patients who are refractory to lenalidomide

{"name":"Test your knowledge on managing a patient newly diagnosed with MM and ineligible for stem-cell transplant", "url":"https://www.quiz-maker.com/QGN8YXV8S","txt":"The induction regimen of daratumumab, lenalidomide, and dexamethasone is appropriate for induction therapy for a newly diagnosed transplant-ineligible patient given its ability to achieve which of the following?, Bone disease in multiple myeloma is a result of which of the following?, The results of the EMNO11\/HOVON114 trial demonstrated which of the following, regarding KPd?","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}

Make your own Quiz